Apelacio, Alvie T.
HRN: 21-65-09 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/15/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/15/2022
08/22/2022
IV
500mg
Q8
Abscess Right Lower Lip
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Skin & Soft TissueEye, Ear, Nose, Throat, & Mouth Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes